Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenB-4C Vaccine in Children and Adolescents With Autoimmune Rheumatic Diseases
NCT07252804Phase 4Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal group B vaccine (recombinant) in invasive meningococcal disease (IMD), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Feb 2026; status: recruiting.
02
Drugs
meningococcal group B vaccine (recombinant)
03
Conditions
invasive meningococcal disease (IMD)
Beyond the preview
Go deeper on NCT07252804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07252804.